Brief: Kintara Therapeutics Posts Qtrly Net Loss Per Share $0.11
13/05/2022 13:17
May 13 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS ANNOUNCES FISCAL 2022 THIRD QUARTER
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* KINTARA THERAPEUTICS INC - AT MARCH 31, 2022, KINTARA HAD
CASH
AND CASH EQUIVALENTS OF APPROXIMATELY $8.8 MILLION
* KINTARA THERAPEUTICS INC - FOR THREE MONTHS ENDED MARCH
31,
2022, KINTARA REPORTED A NET LOSS OF APPROXIMATELY $5.4 MILLION,
OR $0.11 PER SHARE
Source text for Eikon: ID:nPn9TZYyFa
Further company coverage: KTRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.